Nuoncology Labs Inc (NLAB.PK) Quote| Reuters.com
Edition:
United States

Nuoncology Labs Inc (NLAB.PK)

NLAB.PK on OTC Markets Group

0.00USD
17 Jun 2016
Change (% chg)

-- (--)
Prev Close
$0.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
7,825
52-wk High
$0.00
52-wk Low
$0.00

NLAB.PK

Chart for NLAB.PK

About

NuOncology Labs, Inc. is a development stage company engaged in the cancer research & clinical testing laboratories industries. In its pharmaceutical research NuOncology Labs engages in research, development, testing and licensing of promising pharmaceuticals and other cancer treatments. In its clinical laboratory business, the... (more)
No analyst recommendations are available for NLAB.PK.

Overall

Beta: -2.57
Market Cap(Mil.): $0.02
Shares Outstanding(Mil.): 18.86
Dividend: --
Yield (%): --

Financials

  NLAB.PK Industry Sector
P/E (TTM): -- 54.72 34.11
EPS (TTM): -- -- --
ROI: -- 5.50 14.23
ROE: -- 8.71 15.46

Competitors

Earnings vs. Estimates

No consensus analysis data available.

Analyst Research Reports

Report Title Price
Provider : Reuters Investment Profile
$20.00
Provider : Pechala's Reports
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.